{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:25:29Z","timestamp":1793917529457,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim Corp USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.taap.2026.118042","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:29:05Z","timestamp":1789860545000},"page":"118042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling"],"prefix":"10.1016","volume":"517","author":[{"given":"Hangyu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit P.","family":"Laddha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Manautou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.118042_bb0005","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1124\/jpet.108.136523","article-title":"The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene","volume":"325","author":"Abla","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2026.118042_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.taap.2026.118042_bb0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nmeth854","article-title":"3\u2019 UTR seed matches, but not overall identity, are associated with RNAi off-targets","volume":"3","author":"Birmingham","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.taap.2026.118042_bb0020","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1073\/pnas.0703882104","article-title":"Breaking up the correlation between efficacy and toxicity for nonviral gene delivery","volume":"104","author":"Breunig","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2026.118042_bb0025","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1074\/jbc.RA117.000808","article-title":"High dietary fat and sucrose result in an extensive and time-dependent deterioration in health of multiple physiological systems in mice","volume":"293","author":"Burchfield","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2026.118042_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1124\/jpet.120.000291","article-title":"Transporter activity changes in nonalcoholic steatohepatitis: assessment with plasma Coproporphyrin I and III","volume":"376","author":"Chatterjee","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2026.118042_bb0035","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","article-title":"Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease","volume":"55","author":"Chen","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2026.118042_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp700114j","article-title":"Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity","volume":"5","author":"Cheng","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.taap.2026.118042_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2015.11.008","article-title":"Lipid-based transfection reagents can interfere with cholesterol biosynthesis","volume":"495","author":"Danielli","year":"2016","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2026.118042_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/toxsci\/kfaa032","article-title":"Lack of multidrug resistance-associated protein 4 prolongs partial hepatectomy-induced hepatic steatosis","volume":"175","author":"Donepudi","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2026.118042_bb0055","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001299RR","article-title":"Multidrug resistance-associated protein 4 (Mrp4) is a novel genetic factor in the pathogenesis of obesity and diabetes","volume":"35","author":"Donepudi","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2026.118042_bb0060","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.2174\/13816128113199990381","article-title":"Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2026.118042_bb0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver (EASL)","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2026.118042_bb0070","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2026.118042_bb0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2026.118042_bb0080","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1124\/dmd.111.041012","article-title":"Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease","volume":"39","author":"Hardwick","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2026.118042_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd3010","article-title":"Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application","volume":"9","author":"Jackson","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2026.118042_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2006","article-title":"Strategies for silencing human disease using RNA interference","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.taap.2026.118042_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108463","article-title":"Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis","volume":"85","author":"Kim","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.taap.2026.118042_bb0100","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s43440-024-00665-7","article-title":"Obesity-related drug transporter expression alterations in human liver and kidneys","volume":"76","author":"Kosicka-Noworzy\u0144","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.taap.2026.118042_bb0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/lipd.12121","article-title":"Molecular characterization of microvesicular and macrovesicular steatosis shows widespread differences in metabolic pathways","volume":"54","author":"Kristiansen","year":"2019","journal-title":"Lipids"},{"key":"10.1016\/j.taap.2026.118042_bb0110","article-title":"Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials","author":"Lackner","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2026.118042_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167037","article-title":"Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: a comprehensive mechanistic review","volume":"1870","author":"Laddha","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.taap.2026.118042_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123895","article-title":"MRP4 deficiency drives lipid metabolism dysregulation and adipose tissue inflammation through cAMP-CREB-CRTC2 activation","volume":"379","author":"Laddha","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2026.118042_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/oby.22353","article-title":"Blackcurrant (Ribes nigrum) prevents obesity-induced nonalcoholic steatohepatitis in mice","volume":"27","author":"Lee","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.taap.2026.118042_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4132\/jptm.2020.03.07","article-title":"A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy","volume":"54","author":"Lee","year":"2020","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/j.taap.2026.118042_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40360-018-0230-5","article-title":"Cationic liposomes induce cytotoxicity in HepG2 via regulation of lipid metabolism based on whole-transcriptome sequencing analysis","volume":"19","author":"Li","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2026.118042_bb0140","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.taap.2026.118042_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/JOE-16-0649","article-title":"Glucagon-induced extracellular cAMP regulates hepatic lipid metabolism","volume":"234","author":"Lv","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.taap.2026.118042_bb0150","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2026.118042_bb0155","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.21158","article-title":"Mrp4\u2212\/\u2212 mice have an impaired cytoprotective response in obstructive cholestasis","volume":"43","author":"Mennone","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2026.118042_bb0160","doi-asserted-by":"crossref","first-page":"18548","DOI":"10.1038\/s41598-020-75604-6","article-title":"Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy","volume":"10","author":"Minamikawa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2026.118042_bb0165","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.taap.2026.118042_bb0170","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41467-023-37209-1","article-title":"Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease","volume":"14","author":"Powell","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2026.118042_bb0175","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2026.118042_bb0180","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules","volume":"29","author":"Russel","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.taap.2026.118042_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001539","article-title":"Bile acid signaling in MASLD: from pathogenesis to therapeutic applications","author":"Simbrunner","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2026.118042_bb0190","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"Thoolen","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2026.118042_bb0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cellsig.2018.06.005","article-title":"Role of cAMP and phosphodiesterase signaling in liver health and disease","volume":"49","author":"Wahlang","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.taap.2026.118042_bb0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3892\/ijmm.2021.4947","article-title":"Role of 2-series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non-alcoholic fatty liver disease (review)","volume":"47","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.taap.2026.118042_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117046","article-title":"A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice","volume":"491","author":"Willett","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2026.118042_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7150\/ijbs.87305","article-title":"The role of nuclear receptors in the pathogenesis and treatment of non-alcoholic fatty liver disease","volume":"20","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:48:41Z","timestamp":1793915321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26003388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0041008X26003388"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.118042","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.118042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118042"}}